CN Patent

CN1197564C — 海狗油在制备治疗脂代谢紊乱药物中的应用

Assigned to China Biochemical Pharmaceutical Industry Association · Expires 2005-04-20 · 21y expired

What this patent protects

本发明涉及的是将海狗油作为制备治疗脂代谢紊乱(高血脂)药的应用，研究人员发现，将本发明所述的海狗油在2.2-8.6ml/kg口服剂量下，连续灌胃给药，对高脂饲料导致的大鼠、家兔的脂代谢紊乱(高血脂)，可明显降低其血清胆固醇、甘油三酯(TG)水平，升高HDL水平，从而证实将所述的海狗油作为药的情形下，在较大剂量时有明显的治疗脂代谢紊乱(高血脂)的作用。

USPTO Abstract

本发明涉及的是将海狗油作为制备治疗脂代谢紊乱(高血脂)药的应用，研究人员发现，将本发明所述的海狗油在2.2-8.6ml/kg口服剂量下，连续灌胃给药，对高脂饲料导致的大鼠、家兔的脂代谢紊乱(高血脂)，可明显降低其血清胆固醇、甘油三酯(TG)水平，升高HDL水平，从而证实将所述的海狗油作为药的情形下，在较大剂量时有明显的治疗脂代谢紊乱(高血脂)的作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN1197564C
Jurisdiction
CN
Classification
—
Expires
2005-04-20
Drug substance claim
No
Drug product claim
No
Assignee
China Biochemical Pharmaceutical Industry Association
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.